Company Focus

Bayer

Latest Bayer News

Bayer backs CEO Bill Anderson with contract extension through 2029
Pharmaceutical
Bayer is giving chief executive Bill Anderson more time to deliver on his ambitious efforts to reshape the German group, extending his contract by three years to March 2029. The move signals strong support from the company’s supervisory board, which voted unanimously in favor of the renewal.   17 July 2025


Insights

Company Spotlight

Latest News & Features of interest to Bayer

Latest Ones To Watch News of interest to Bayer

Once seen as a niche tool for rare tumors, theranostics is quickly becoming a new standard in cancer care. Combining diagnostics and therapy in a single platform, the field has drawn billions in pharma investment and sparked regulatory momentum, as precision imaging begins to guide not only what patients receive—but when, how often, and with what expected impact.   18 July 2025

More in M&A >


Ones to Watch Companies of interest to Bayer

Reset all filters
Refine Search